News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,261 Results
Type
Article (7390)
Company Profile (41)
Press Release (171822)
Multimedia
Podcasts (22)
Webinars (4)
Section
Business (49001)
Career Advice (492)
Deals (9630)
Drug Delivery (21)
Drug Development (34328)
Employer Resources (20)
FDA (4478)
Job Trends (3778)
News (93658)
Policy (6591)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (508)
Academic (1)
Accelerated approval (14)
Adcomms (10)
Allergies (64)
Alliances (8309)
ALS (71)
Alzheimer's disease (707)
Antibody-drug conjugate (ADC) (133)
Approvals (4734)
Artificial intelligence (133)
Autoimmune disease (65)
Automation (11)
Bankruptcy (65)
Best Places to Work (3505)
BIOSECURE Act (7)
Biosimilars (63)
Biotechnology (31)
Bladder cancer (85)
Brain cancer (23)
Breast cancer (333)
Cancer (2424)
Cardiovascular disease (193)
Career advice (394)
Career pathing (8)
CAR-T (96)
CDC (8)
Celiac Disease (1)
Cell therapy (278)
Cervical cancer (12)
Clinical research (31552)
Collaboration (492)
Compensation (161)
Complete response letters (17)
COVID-19 (803)
CRISPR (34)
C-suite (181)
Cystic fibrosis (68)
Data (3665)
Denatured (1)
Depression (62)
Diabetes (277)
Diagnostics (1714)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (77)
Drug pricing (26)
Drug shortages (2)
Duchenne muscular dystrophy (80)
Earnings (34492)
Editorial (17)
Employer branding (1)
Employer resources (21)
Events (30643)
Executive appointments (213)
FDA (6074)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (496)
Gene editing (75)
Generative AI (7)
Gene therapy (246)
GLP-1 (460)
Government (922)
Grass and pollen (4)
Guidances (305)
Healthcare (4794)
HIV (26)
Huntington's disease (18)
IgA nephropathy (72)
Immunology and inflammation (100)
Immuno-oncology (31)
Indications (63)
Infectious disease (918)
Inflammatory bowel disease (87)
Inflation Reduction Act (2)
Influenza (65)
Intellectual property (91)
Interviews (92)
IPO (5962)
IRA (7)
Job creations (504)
Job search strategy (329)
JPM (22)
Kidney cancer (13)
Labor market (22)
Layoffs (96)
Leadership (10)
Legal (882)
Liver cancer (39)
Longevity (4)
Lung cancer (370)
Lymphoma (227)
Machine learning (12)
Management (6)
Manufacturing (171)
MASH (89)
Medical device (2950)
Medtech (2961)
Mergers & acquisitions (4111)
Metabolic disorders (617)
Multiple sclerosis (67)
NASH (6)
Neurodegenerative disease (133)
Neuropsychiatric disorders (38)
Neuroscience (1244)
NextGen: Class of 2026 (1265)
Non-profit (650)
Now hiring (3)
Obesity (251)
Opinion (56)
Ovarian cancer (74)
Pain (98)
Pancreatic cancer (112)
Parkinson's disease (141)
Partnered (9)
Patents (141)
Patient recruitment (220)
Peanut (22)
People (8413)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase 1 (9216)
Phase 2 (15474)
Phase 3 (10192)
Pipeline (3072)
Policy (55)
Postmarket research (888)
Preclinical (2956)
Press Release (7)
Prostate cancer (114)
Psychedelics (17)
Radiopharmaceuticals (100)
Rare diseases (372)
Real estate (581)
Recruiting (11)
Regulatory (6609)
Reports (22)
Research institute (517)
Resumes & cover letters (97)
Rett syndrome (15)
RNA editing (4)
RSV (35)
Schizophrenia (80)
Series A (118)
Series B (60)
Service/supplier (1)
Sickle cell disease (44)
Special edition (10)
Spinal muscular atrophy (47)
Sponsored (15)
Startups (711)
State (1)
Stomach cancer (5)
Supply chain (20)
Tariffs (20)
The Weekly (21)
Vaccines (319)
Venture capital (26)
Weight loss (140)
Women's health (24)
Worklife (6)
Date
Last 7 days (230)
Last 30 days (736)
Last 365 days (12789)
2026 (1293)
2025 (12984)
2024 (13515)
2023 (14784)
2022 (17492)
2021 (17689)
2020 (15676)
2019 (11147)
2018 (8294)
2017 (8639)
2016 (7272)
2015 (8840)
2014 (5989)
2013 (4071)
2012 (4255)
2011 (4684)
2010 (4184)
Location
Africa (172)
Alabama (16)
Alaska (1)
Arizona (48)
Arkansas (3)
Asia (11239)
Australia (1873)
California (4803)
Canada (1341)
China (486)
Colorado (174)
Connecticut (253)
Delaware (170)
Europe (26992)
Florida (642)
Georgia (150)
Hawaii (2)
Idaho (12)
Illinois (295)
India (25)
Indiana (198)
Iowa (5)
Japan (211)
Kansas (46)
Kentucky (16)
Louisiana (8)
Maine (27)
Maryland (499)
Massachusetts (3329)
Michigan (88)
Minnesota (197)
Mississippi (3)
Missouri (39)
Montana (5)
Nebraska (2)
Nevada (48)
New Hampshire (12)
New Jersey (1434)
New Mexico (3)
New York (1282)
North Carolina (401)
North Dakota (2)
Northern California (2410)
Ohio (85)
Oklahoma (1)
Oregon (9)
Pennsylvania (965)
Puerto Rico (3)
Rhode Island (6)
South America (290)
South Carolina (2)
Southern California (1895)
Tennessee (42)
Texas (731)
United States (16092)
Utah (94)
Vermont (1)
Virginia (87)
Washington D.C. (26)
Washington State (341)
Wisconsin (28)
179,261 Results for "a2 biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Press Releases
A2 Biotherapeutics Presents Initial Safety and Efficacy Data from Ongoing Phase 1/2 EVEREST-2 Study, Including First Report of a Complete Response to CAR T-Cell Therapy in a Patient with NSCLC
November 10, 2025
·
8 min read
Press Releases
A2 Biotherapeutics Presents Data from Ongoing Phase 1/2 EVEREST-2 Study During the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer
September 9, 2025
·
6 min read
Press Releases
Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration
January 29, 2026
·
2 min read
Press Releases
Arcutis Biotherapeutics, Inc. Announces Termination of Promotion Agreement with Kowa
January 27, 2026
·
5 min read
Press Releases
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
February 3, 2026
·
6 min read
Press Releases
FORE Biotherapeutics Presents Phase 1/2a Plixorafenib Data Demonstrating Prolonged Duration of Effect in BRAF Altered Thyroid Cancers at American Thyroid Association® 2025 Annual Meeting
September 15, 2025
·
6 min read
Press Releases
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
February 5, 2026
·
3 min read
Press Releases
Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026
January 29, 2026
·
8 min read
Press Releases
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
January 12, 2026
·
7 min read
1 of 17,927
Next
